1. 1183. Serum Bactericidal Activity Induced by Live Attenuated Pertussis Vaccine BPZE1 is Comparable to Boostrix™. (4th December 2021) Authors: Keech, Cheryl A; Gorringe, Andrew; Cavell, Breeze; Goldstein, Peter; Rubin, Keith Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1183. Serum Bactericidal Activity Induced by Live Attenuated Pertussis Vaccine BPZE1 is Comparable to Boostrix™. (4th December 2021) Authors: Keech, Cheryl A; Gorringe, Andrew; Cavell, Breeze; Goldstein, Peter; Rubin, Keith Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial. Issue 10379 (11th March 2023) Authors: Keech, Cheryl; Miller, Vicki E; Rizzardi, Barbara; Hoyle, Christopher; Pryor, Melinda J; Ferrand, Jonathan; Solovay, Ken; Thalen, Marcel; Noviello, Stephanie; Goldstein, Peter; Gorringe, Andrew; Cavell, Breeze; He, Qiushui; Barkoff, Alex-Mikael; Rubin, Keith; Locht, Camille Journal: Lancet Issue: Volume 401:Issue 10379(2023) Page Start: 843 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults. Issue 47 (8th November 2022) Authors: Buddy Creech, C.; Jimenez-Truque, Natalia; Kown, Naomi; Sokolow, Katherine; Brady, Eric J.; Yoder, Sandra; Solovay, Ken; Rubin, Keith; Noviello, Stephanie; Hensel, Elizabeth; Selamawi, Semhal; Bakare, Adetunji; Makowski, Mat; Lu, Kristina Journal: Vaccine Issue: Volume 40:Issue 47(2022) Page Start: 6740 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. Issue 11 (November 2020) Authors: Jahnmatz, Maja; Richert, Laura; al-Tawil, Nabil; Storsaeter, Jann; Colin, Céline; Bauduin, Claire; Thalen, Marcel; Solovay, Ken; Rubin, Keith; Mielcarek, Nathalie; Thorstensson, Rigmor; Locht, Camille; Dager, Lena; Ekholm, Nina; Gustafsson, Margareta; Linde, Åsa; Lång, Cecilia; Nastase, Maria; Re... Journal: Lancet infectious diseases Issue: Volume 20:Issue 11(2020) Page Start: 1290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The pertussis hypothesis: Bordetella pertussis colonization in the etiology of asthma and diseases of allergic sensitization. (November 2018) Authors: Rubin, Keith; Glazer, Steven Journal: Medical hypotheses Issue: Volume 120(2018) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗